Digilab BioVision (www.peptidomics.com) inked a licensing agreement with GenWay Biotech (www.genwaybio.com). Under the terms of the agreement, Digilab’s location in Hannover, Germany, will become the European Seppro® Center. This agreement broadens Digilab’s portfolio of preanalytical products and services by offering GenWay’s Seppro IgY technology. Seppro IgY selectively partitions the 12 most abundant proteins from human serum or plasma.
